Artículos del autor

Dr. Andrés Rodríguez

Member of the Editorial Board of solaci.org
Chronic Ischemic cardiopathy

Smoking and Its Impact on Cardiovascular Disease 10 Years After Coronary Angioplasty

Smoking is a well-established risk factor for atherosclerotic cardiovascular diseases. However, some historical reports have suggested a...
Dr. Andrés Rodríguez -
Structural heart disease

5th Generation Balloon Expandable Valve in a Real World US Population: One-Year Outcomes

Transcatheter aortic valve replacement (TAVR) has consolidated as treatment for severe symptomatic aortic stenosis, even in low...
Dr. Andrés Rodríguez -
Aorta

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of...
Dr. Andrés Rodríguez -
Antiplatelet

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a...
Dr. Andrés Rodríguez -
Bifurcations

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary...
Dr. Andrés Rodríguez -
Femoropopliteal

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery...
Dr. Andrés Rodríguez -
Chronic Coronary Syndromes

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization....
Dr. Andrés Rodríguez -
Coronary disease

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD)....
Dr. Andrés Rodríguez -